RocketTickers

Aurinia Announces Positive Topline Results From the AURORA 2 Con

Long
NASDAQ:AUPH   Aurinia Pharmaceuticals Inc
AUPH: Aurinia Pharmaceuticals Inc.
2021-12-09 06:15:00
Aurinia Announces Positive Topline Results From the AURORA 2 Continuation Study of LUPKYNIS™ (voclosporin) for the Treatment of Adults With Active Lupus Nephritis (LN)
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.